Document is current
Any future updates will be listed below
-
Authors
Lana, Raquel
Nekkab, Narimane
Siqueira, Andre M.
Peterka, Cassio
Marchesini, Paola
Lacerda, Marcus
Mueller, Ivo
White, Michael http://orcid.org/0000-0002-7472-4138
Villela, Daniel
-
Funding
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (424141/2018-3)
Medicines for Malaria Venture
- License Information
-
More Information
Article History
Received: 11 August 2020
Accepted: 29 January 2021
First Online: 12 February 2021
Ethics approval and consent to participate
: This study only involved analysis of secondary databases with anonymized information, which did nor require Ethics approval and/or consent to participate.
: This work did nor require consent for publication.
: This work received funding from Medicines for Malaria Venture (MMV) for studying the impact of introduction of tafenoquine in the <i>Plasmodium vivax</i> control.
